Skip to content

Can new imaging techniques help us to detect umbilical cord abnormalities in pregnancy?

Coiling of the Umbilical cord in pRegnancy and LIfelong health (CURLI)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN12483905
Enrollment
50
Registered
2026-06-03
Start date
2026-04-10
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Placental dysfunction Pregnancy and Childbirth

Interventions

We will recruit pregnant participants at any point from 12+0 weeks' gestation up until delivery. When recruited before 30 weeks' gestation, participants will be invited to up to three study visits du

Sponsors

Accord (United Kingdom)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
16 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Aged 16-50 years 2. Able to give informed consent 3. Singleton non-anomalous viable pregnancy with gestational age >12 completed weeks 4. Pregnancy booked in NHS Lothian 5. No contraindication to MRI

Exclusion criteria

Exclusion criteria: 1. Women who are not pregnant 2. Aged under 16 or over 50 years 3. Women who are classified as Adults with Incapacity (AWI) as determined by midwife, GP, or research team 4. Multiple pregnancy 5. Diagnosed major congenital abnormality affecting fetal cardiovascular or nervous system 6. Contraindication to MRI (presence of non-compatible prostheses, implants, conductors or metallic foreign bodies, severe claustrophobia)

Design outcomes

Primary

MeasureTime frame
Placental and umbilical cord features, including measures of umbilical cord diameter and coiling and placental oxygenation, measured using ultrasound and MRI imaging at antenatal study visits (between 12+0 weeks' gestation and birth)

Secondary

MeasureTime frame
Blood levels of angiogenic factors (PlGF and sFlt-1) measured using immunoassay at antenatal study visits (between 12+0 weeks' gestation and birth);Maternal and fetal Doppler indices and fetal biometry measured using ultrasound at antenatal study visits (between 12+0 weeks' gestation and birth);Macroscopic features and placenta and umbilical cord specimens measured using visual inspection at up to 24 hours after birth;Microscopic features of placenta and umbilical cord specimens measured using histological examination of prepared tissue sections at up to 3 months after birth;Clinical pregnancy outcomes measured using electronic health records at up to 2 weeks after birth

Countries

Scotland, United Kingdom

Contacts

Public ContactRosemary Townsend
rtownse2@ed.ac.uk+44 (0)7740285018

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 23, 2026